REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Apteka Kwiecien sp. j. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Lessors of Real Estate | Advertising Agencies | Marketing Research and Public Opinion Polling
Full name: Apteka Kwiecien sp. j. Profile Updated: April 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Apteka Kwiecien sp. j. is an enterprise in Poland, with the main office in Krakow. The enterprise currently operates in the Department Stores sector. The company was established on November 24, 2006. The latest financial highlights indicate a net sales revenue increase of 13.98% in 2022. Over the same period, its total assets grew by 4.08%. The net profit margin of Apteka Kwiecien sp. j. increased by 0.09% in 2022.

Headquarters
Ul. Lakowa 17
Krakow; Malopolskie; Postal Code: 31-443

Contact Details: Purchase the Apteka Kwiecien sp. j. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteka Kwiecien sp. j. report to view the information.
Incorporation Date:
November 24, 2006
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Apteka Kwiecien sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
13.98%▲
Total operating revenue
14.04%▲
Operating profit (EBIT)
134.15%▲
Net Profit (Loss) for the Period
25.46%▲
Total assets
4.08%▲
Total equity
18.96%▲
Operating Profit Margin (ROS)
0.52%▲
Net Profit Margin
0.09%▲
Return on Equity (ROE)
0.68%▲
Quick Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo